Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial

Name: Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial
SKU: 2744
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 2 Articles Tags: aripiprazole, atypical-antipsychotics, bs, ccrc, gerardo-villarreal, gregory-toney, jacob-pickard, jose-m-cañive-md, lawrence-a-calais, ma, md, pharmd, ptsd, rn, s-laura-lundy

Description

Description

Jose M. Cañive MD Link

ORIGINAL RESEARCH

Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Post Traumatic Stress Disorder: An Open Trial

Gerardo Villarreal, MD, Lawrence A. Calais, RN, CCRC, Jose M. Cañive MD, S. Laura Lundy, BS, Jacob Pickard, MA, and Gregory Toney, PharmD

PB-40-2-02-Canive

Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial

Description

Jose M. Cañive MD Link

ORIGINAL RESEARCH

Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Post Traumatic Stress Disorder: An Open Trial

Gerardo Villarreal, MD, Lawrence A. Calais, RN, CCRC, Jose M. Cañive MD, S. Laura Lundy, BS, Jacob Pickard, MA, and Gregory Toney, PharmD

Terence A. Ketter, MD: Mood Stabilizers and Atypical Antipsychotics: Bimodal Treatments for Bipolar Disorder

The Utilization of Atypical Antipsychotics in the Pain Medicine Physician’s Armamentarium

New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD

Jeffrey Alderman, PhD: The Effect of Food on the Absorption of Oral Ziprasidone

Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial

Description

Jose M. Cañive MD Link

ORIGINAL RESEARCH

Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Post Traumatic Stress Disorder: An Open Trial

Gerardo Villarreal, MD, Lawrence A. Calais, RN, CCRC, Jose M. Cañive MD, S. Laura Lundy, BS, Jacob Pickard, MA, and Gregory Toney, PharmD

Related products

Terence A. Ketter, MD: Mood Stabilizers and Atypical Antipsychotics: Bimodal Treatments for Bipolar Disorder

The Utilization of Atypical Antipsychotics in the Pain Medicine Physician’s Armamentarium

New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD

Jeffrey Alderman, PhD: The Effect of Food on the Absorption of Oral Ziprasidone